Primary vs Secondary Focal Segmental Glomerulosclerosis

Dr. Musab Hommos, a 3rd Year Fellow in Nephrology and Dr. Fernando Fervenza, a Nephrologist, both at Mayo Clinic in Rochester, MN, review results of their study appearing in the December 2017 issue of Mayo Clinic Proceedings, which was the first to comprehensively categorize the significance between primary and secondary incidents of focal segmental glomerulosclerosis, aiding clinicians in discriminating which patients would best benefit from immunosuppressive treatment. Available at: tinyurl.com/ycaqehjd